Concourse Financial Group Securities, Inc. 9 Meters Biopharma, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

10 transactions

Quarter	Operation	Price Per share
Q3 2022 Nov 15, 2022	BUY	$0.21 - $0.32 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$0.26 - $0.64 $0 - $0
Q1 2022 May 09, 2022	BUY	$0.52 - $1.0 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$0.85 - $1.33 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$1.03 - $1.41 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$1.04 - $1.5 $0 - $0
Q1 2021 May 13, 2021	BUY	$0.84 - $2.16 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$0.65 - $1.11 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$0.48 - $0.84 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$0.43 - $0.74 $0 - $0

Others Institutions Holding NMTR

# of Institutions

Shares Held

67.9K

Call Options Held

Put Options Held

View Full List

About 9 METERS BIOPHARMA, INC.

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

More about NMTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account